相关实验视频
Updated: Jul 28, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
521
慢性肥胖管理的药物治疗:展望未来的未来
Mariana Abdel-Malek1, Lisa Yang2, Alexander Dimitri Miras3,4
1Imperial College Healthcare NHS Trust, London, UK. M.abdel-malek@nhs.net.
Internal and emergency medicine
|May 30, 2023
概括
新的肥胖药物,如蒂尔泽帕提德,显示显著的体重减轻和改善血糖控制. 肠道激素疗法的这些进步为管理肥胖和相关疾病提供了有希望的选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
- 内分泌学 在内分泌学.
背景情况:
- 肥胖大流行及其代谢性共患病症需要新的治疗药物.
- 肠-大脑分子通路的进步为药物发现提供了信息.
- 基于葡萄糖类1 (GLP-1) 的疗法已经显示出有效性.
研究的目的:
- 审查肠道荷尔蒙生物学最近的进展,用于下一代药物治疗.
- 评估治疗肥胖和糖尿病的新药的疗效和安全性.
- 为慢性肥胖管理提供新兴疗法的概述.
主要方法:
- 对临床试验数据的审查,包括SURPASS和SURMOUNT试验.
- 分析蒂尔泽帕提德在减肥和血糖控制方面的疗效.
- 基于氨酸的组合策略和其他管道治疗的概述.
主要成果:
- 蒂尔泽帕提德 (twincretin) 显示显著减轻了体重.
- 提尔泽帕提德在临床试验中显示出相当大的血糖有效性.
- 新兴疗法,包括氨酸组合,显示出对肥胖管理的希望.
结论:
- 基于肠道激素的新型疗法,如蒂尔泽帕提德,为肥胖和糖尿病治疗提供了显著的潜力.
- 组合策略和新兴药物代表了慢性肥胖管理的未来.
- 对肠-大脑通路的持续研究对于开发更安全,更有效的肥胖药物疗法至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172
Obesity
552
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
552
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K

